Aurora Cannabis Q1 Sales $55.91M Beat $46.80M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aurora Cannabis (NASDAQ:ACB) reported Q1 sales of $75.10 million, beating the analyst consensus estimate of $46.80 million by 60.47 percent. This represents a 98.85 percent increase over sales of $37.77 million in the same period last year.
August 10, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aurora Cannabis significantly exceeded Q1 sales estimates, indicating strong performance and potential growth.
Aurora Cannabis' Q1 sales significantly exceeded analyst estimates, which is typically a positive signal for the company's performance and could lead to a short-term increase in the stock price. The 98.85% YoY increase further strengthens this outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100